HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

Triplet Therapy Determination Phase 3 Trial | Paul Richardson, MD | ASH 2023

Posted by
HealthTree Logo HealthTree
• December 27, 2023

Description

Paul Richardson presents Triplet Therapy Determination Phase 3 Trial at ASH 2023.

On this video

Healthtree contact Paul Richardson, MD, Specialist

Paul Richardson, MD, Specialist

Dana Farber Cancer Institute

Related Content

  • Video Etentamig in Heavily Pretreated Myeloma: Phase 3 CERVINO Results | IMS 2026 #myeloma
  • Video BCMA Bispecifics in Myeloma: Do Real-World Results Match Clinical Trials? | IMS 2026
  • Video KRd Lowers Progression Risk in High-Risk Smoldering Myeloma | IMS 2026
  • Video Iberdomide + Daratumumab More Than Doubles MRD-Negative Rates in Myeloma -EXCALIBER | IMS 2026
  • Video Belantamab + VRd for Newly Diagnosed Myeloma: What DREAMM-9 Shows About Vision
  • Video PERSEUS 6-Year Results: D-VRd Improves Myeloma PFS & Supports Dual Maintenance | IMS 2026